Premium
Risks and benefits of new benzodiazepine black box
Author(s) -
Knopf Alison
Publication year - 2021
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32972
Subject(s) - black box , food and drug administration , benzodiazepine , unintended consequences , addiction , medicine , psychiatry , medical emergency , political science , computer science , law , receptor , artificial intelligence
The Food and Drug Administration (FDA) is requiring a black box warning for benzodiazepines, which is warranted for some reasons but could cause unintended consequences, Matthew E. Hirschtritt, M.D., M.P.H., from California has warned. In addition to the new black box, which would explicitly “address the serious risks of abuse, addiction, physical dependence, and withdrawal reactions” among this class of medications, the FDA is modifying prescribing information, direction physicians to.